Patient Characteristics (n = 22)
| Variable | At diagnosis | Histopathology |
|---|---|---|
| ISUP score (n) | ||
| 1 (Gleason 6) | 5 (22.7%) | 1 (4.5%) |
| 2 (Gleason 7 [3 + 4]) | 6 (27.3%) | 9 (40.9%) |
| 3 (Gleason 7 [4 + 3]) | 4 (18.2%) | 2 (9.1%) |
| 4 (Gleason 8) | 2 (9.1%) | 3 (13.6%) |
| 5 (Gleason > 8) | 5 (22.7%) | 7 (31.8%) |
| TNM stage (n) | ||
| T2a | 19 (86.4%) | 0 (0.0%) |
| T2c | 3 (13.6%) | 6 (27.3%) |
| T3a | 0 (0.0%) | 11 (50.0%) |
| T3b | 0 (0.0%) | 5 (22.7%) |
| N0 | 0 (0.0%) | 20 (90.9%) |
| N1 | 0 (0.0%) | 1 (4.5%) |
| Nx | 22 (100.0%) | 1 (4.5%) |
| Age (y) | ||
| Mean | 64.0 (SD, 5.9) | |
| Median | 65 (Q1–Q3, 59–68) | |
| Minimum–maximum | 52–75 | |
| PSA (ng/mL) | ||
| Mean | 8.3 (SD, 4.0) | |
| Median | 7 (Q1–Q3, 6–9) | |
| Minimum–maximum | 3–21 |